Home About Us Director's Corner Program Types How to Subscribe
Skip Navigation
U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality
Agency for Healthcare Research Quality
Healhtcare 411 Search
Healhtcare 411 Home Page
Help
View All Programs
AUDIO TRANSCRIPT
Wednesday, August 27, 2008 9:00 AM
Listen
Radiocast: Prostate Cancer Screening Not Recommended For 75+

Debra: This is Healthcare 411: Information for better health. The leading independent panel of experts in prevention and primary care recommend that men 75 and older not be screened for prostate cancer. U.S. Preventive Services Task Force member Dr. Michael LeFevre:

Dr. LeFevre: Most prostate cancers detected by screening in older men, mainly through PSA testing, are slow-growing and would rarely affect one’s health. The benefits of treating these cancers are minimal to none. And the potential harms from treatment include erectile dysfunction, urinary incontinence, bowel dysfunction, and even death.

Debra: Should men younger than 75 be screened?

Dr. LeFevre: Younger men should talk with their clinicians about the possible, but uncertain benefits of screening and the risks of testing and treatment before deciding if prostate cancer screening is right for them.

Debra: To learn more about this and other health topics, go to healthcare411.ahrq.gov. Healthcare 411 is produced by AHRQ, the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services. I’m Debra James for Healthcare 411.
 


Subscribe to our Podcasts
Need Help?

E-mail this program to a friend

Print this page



AHRQ
Advancing Excellence in Health Care
HHS Home Contact Us